BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7977738)

  • 1. Transient stabilization of cholecystokinin A receptor mRNA by glucocorticoids in pancreatic AR42J cells.
    Rosewicz S; Riecken EO; Kaiser A
    Am J Physiol; 1994 Nov; 267(5 Pt 1):G772-7. PubMed ID: 7977738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoids increase cholecystokinin receptors and amylase secretion in pancreatic acinar AR42J cells.
    Logsdon CD
    J Biol Chem; 1986 Feb; 261(5):2096-101. PubMed ID: 2418020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient agonist-induced regulation of the cholecystokinin-A and cholecystokinin-B receptor mRNA levels in rat pancreatic acinar AR42J cells.
    Günther R; Carstens OC; Schmidt WE; Fölsch UR
    Pancreatology; 2003; 3(1):47-54. PubMed ID: 12649564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of intestinal cholecystokinin gene expression by glucocorticoids.
    Ratineau C; Roche C; Chuzel F; Cordier-Bussai M; Blanc M; Bernard C; Cuber JC; Chayvialle JA
    J Endocrinol; 1996 Oct; 151(1):137-45. PubMed ID: 8943778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bombesin receptor gene expression in rat pancreatic acinar AR42J cells: transcriptional regulation by glucocorticoids.
    Rosewicz S; Detjen K; Kaiser A; Prosenc N; Cervos-Navarro J; Riecken EO; Haller H
    Gastroenterology; 1994 Jul; 107(1):208-18. PubMed ID: 8020664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoids stimulate ornithine decarboxylase gene expression in pancreatic AR42J cells.
    Rosewicz S; Logsdon CD
    Gastroenterology; 1991 Oct; 101(4):1102-8. PubMed ID: 1889704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of glucocorticoid receptor down-regulation by glucocorticoids.
    Rosewicz S; McDonald AR; Maddux BA; Goldfine ID; Miesfeld RL; Logsdon CD
    J Biol Chem; 1988 Feb; 263(6):2581-4. PubMed ID: 3343225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholecystokinin receptor characterization and cholecystokinin-A receptor messenger RNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreas.
    Povoski SP; Zhou W; Longnecker DS; Bell RH
    Oncol Res; 1994; 6(9):411-7. PubMed ID: 7703527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of CCK regulation of monitor peptide mRNA expression in pancreatic acinar AR42J cells.
    Kinouchi T; Tsuzuki S; Minami C; Hayashi Y; Sugimoto E; Fushiki T
    Am J Physiol; 1997 Apr; 272(4 Pt 1):G794-801. PubMed ID: 9142910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of cholecystokinin receptors and messenger RNA expression in rat pancreas: evidence for expression of cholecystokinin-A receptors but not cholecystokinin-B (gastrin) receptors.
    Zhou W; Povoski SP; Bell RH
    J Surg Res; 1995 Mar; 58(3):281-9. PubMed ID: 7533864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of expression of the substance P receptor mRNA in pancreatic acinar AR42J cells by glucocorticoids.
    Ihara H; Nakanishi S
    J Biol Chem; 1990 Dec; 265(36):22441-5. PubMed ID: 1702421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoids increase amylase mRNA levels, secretory organelles, and secretion in pancreatic acinar AR42J cells.
    Logsdon CD; Moessner J; Williams JA; Goldfine ID
    J Cell Biol; 1985 Apr; 100(4):1200-8. PubMed ID: 2579957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCK, bombesin, and carbachol stimulate c-fos, c-jun, and c-myc oncogene expression in rat pancreatic acini.
    Lu L; Logsdon CD
    Am J Physiol; 1992 Sep; 263(3 Pt 1):G327-32. PubMed ID: 1415544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ontogeny and species differences in the pancreatic expression and localization of the CCK(A) receptors.
    Bourassa J; Lainé J; Kruse ML; Gagnon MC; Calvo E; Morisset J
    Biochem Biophys Res Commun; 1999 Jul; 260(3):820-8. PubMed ID: 10403848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pig pancreatic acinar cells possess predominantly the CCK-B receptor subtype.
    Morisset J; Levenez F; Corring T; Benrezzak O; Pelletier G; Calvo E
    Am J Physiol; 1996 Aug; 271(2 Pt 1):E397-402. PubMed ID: 8770035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholecystokinin A and B receptor mRNA expression in human pancreas.
    Nishimori I; Kamakura M; Fujikawa-Adachi K; Nojima M; Onishi S; Hollingsworth MA; Harris A
    Pancreas; 1999 Aug; 19(2):109-13. PubMed ID: 10438155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoids regulate pituitary growth hormone-releasing hormone receptor messenger ribonucleic acid expression.
    Miller TL; Mayo KE
    Endocrinology; 1997 Jun; 138(6):2458-65. PubMed ID: 9165036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An animal model of congenital defect of gene expression of cholecystokinin (CCK)-A receptor.
    Funakoshi A; Miyasaka K; Shinozaki H; Masuda M; Kawanami T; Takata Y; Kono A
    Biochem Biophys Res Commun; 1995 May; 210(3):787-96. PubMed ID: 7539259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glandular kallikrein gene expression is selectively down-regulated by glucocorticoids in pancreatic AR42J cells.
    Rosewicz S; Detjen K; Logsdon CD; Chen LM; Chao J; Riecken EO
    Endocrinology; 1991 May; 128(5):2216-22. PubMed ID: 2019248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCKA receptor activation stimulates p130(Cas) tyrosine phosphorylation, translocation, and association with Crk in rat pancreatic acinar cells.
    Ferris HA; Tapia JA; García LJ; Jensen RT
    Biochemistry; 1999 Feb; 38(5):1497-508. PubMed ID: 9931015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.